Related Experiment Video
Updated: Jan 23, 2026

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
Published on: February 6, 2020
Prognostic Significance of CHEK2 Mutation in Progression of Breast Cancer
Narges Ansari1, Saeid Shahrabi2, Abbas Khosravi3
1Isfahan Bone Metabolic Disorders Research Center, Department of Internal Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Abstract:
Breast cancer (BC) is one of the most common cancers among women; genetic mutations reflect the development of this disease. Mutations in cell signaling factors can be the main cause of BC development. In this study, we focused on mutations in checkpoint kinase 2 (CHEK2) and their impact as a prognostic factor in the pathogenesis of BC. CHEK2 is controlled in cell signaling pathways through the influence of upstream genes. Also, several downstream genes are regulated by CHEK2. In addition, mutations in CHEK2 lead to resistance of BC cells to chemotherapy and metastasis of cancer cells to other parts of the body. Finally, detection of mutations in CHEK2 can be used as a prognostic factor for patient response to treatment and for targeting downstream molecules of CHEK2 that are involved in the proliferation of breast tumor cells. Mutations such as c.1100delC and I157T can distinguish which patients are susceptible to metastasis.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mutations
Cancers Originate from Somatic Mutations in a Single Cell
Viral Mutations
Statistical Significance
Cholesterol: Significance and Regulation
Considering cholesterol and...

